Impact of Functional Power Training on Activity in Children with Cerebral Palsy
Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy - A Randomized Controlled Trial
This study tests if Functional Power Training can help children with cerebral palsy, aged 4 to 12, be more active and improve their walking and endurance compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 4 Years to 12 Years |
| Sex | All |
| Sponsor | Amsterdam UMC, location VUmc Academic / other |
| Locations | 10 sites (Emmen, Drenthe and 9 other locations) |
| Trial ID | NCT06640894 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of Functional Power Training (FPT) on improving participation and activity levels in children aged 4 to 12 with cerebral palsy. The approach focuses on enhancing walking ability and endurance, which are critical for social and physical participation. By comparing FPT to usual care, the study aims to provide high-level scientific evidence regarding the efficacy of this training method. The goal is to address the underlying fatigue and physical fitness issues that hinder participation in children with cerebral palsy.
Who should consider this trial
Good fit: Ideal candidates are children aged 4 to 12 with cerebral palsy classified as GMFCS level I-III who have questions about their participation.
Not a fit: Patients with progressive neurological disorders or those who have recently undergone specific treatments like botulinum toxin or orthopedic surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly enhance the physical activity and social participation of children with cerebral palsy.
How similar studies have performed: Previous studies have indicated that functional power training may be more effective than traditional resistance training, suggesting a promising avenue for improving outcomes in similar populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with cerebral palsy or a related non-progressive disorder between the ages of 4 to 12. * Gross Motor Function Classification System (GMFCS) level I - III. * Parents and/or children have a treatment question related to participation of the child. Exclusion Criteria: * Participants that suffer from a progressive neurological disorder. * Treatment with botulinum toxin and/or serial casting in lower extremities planned during the study period. * Treatment with botulinum toxin in the twelve weeks prior to participation in the study. * Treatment with serial casting in the three weeks prior to participation in the study. * Children that underwent a selective dorsal rhizotomy twelve months prior to participation in the study. * Children that underwent orthopedic surgery on their lower extremities in the 12 months before participation in the study. * Children that have received MegaPower training in the last 4 months before participation in the study. * Children for whom walking is not their preferred method of locomotion (yet).
Where this trial is running
Emmen, Drenthe and 9 other locations
- Treant Zorggroep — Emmen, Drenthe, Netherlands (Recruiting)
- Merem — Almere Stad, Flevoland, Netherlands (Recruiting)
- Adelante zorggroep — Valkenburg, Limburg, Netherlands (Recruiting)
- Revant — Breda, North Brabant, Netherlands (Not_yet_recruiting)
- Reade — Amsterdam, North Holland, Netherlands (Recruiting)
- Heliomare — Heemskerk, North Holland, Netherlands (Recruiting)
- Merem — Hilversum, North Holland, Netherlands (Recruiting)
- Roessingh — Enschede, Overijssel, Netherlands (Recruiting)
- Revalidatie Friesland — Beetsterzwaag, Provincie Friesland, Netherlands (Recruiting)
- Revant — Goes, Zeeland, Netherlands (Not_yet_recruiting)
Study contacts
- Principal investigator: Annemieke I. Buizer, prof. dr. — Amsterdam UMC
- Study coordinator: Rijk Dersjant, drs.
- Email: r.dersjant@amsterdamumc.nl
- Phone: +31 20 4440761
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.